An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation

Frontiers in Oncology

Volumn 4 JUN, Issue , 2014, Pages

  Gómez, José Carlos Iglesias ^a   Orgueira, Adrián Mosquera ^a  

^a NONE

Author keywords

Cancer; Integrative analysis; Malignant conversion; Meningioma; No funding research; Transcriptomics; Video presentation; Whole genome

Indexed keywords

ARTICLE; BIOINFORMATICS; CANCER STAGING; DISEASE COURSE; DNA POLYMORPHISM; GENE EXPRESSION; GENE ONTOLOGY; GENETIC ANALYSIS; GENOMICS; GENOTYPE; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MENINGIOMA; PATHOGENESIS; RISK FACTOR; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTOMICS; TUMOR SUPPRESSOR GENE;

EID: 84904707952     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00147     Document Type: Article

References (89)

1. Santosh S, McCarthy BJ, Villano JL. Update on meningiomas. Oncologist (2011) 16:1604-13. doi: 10.1634/theoncologist.2011-0193
2. Perry A, David HG, Guido R. Molecular pathogenesis of meningiomas. J Neurooncol (2004) 70(2):183-202. doi:10.1007/s11060-004-2749-0
3. Fauci AS. Harrison's Principles of Internal Medicine. New York, NY: McGraw-Hill Medical (2008).
4. Yang SY, Park CK, Park SH, Kim DG, Chung YS, Jung HW. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J Neurol Neurosurg Psychiatry (2008) 79(5):574-80. doi:10.1136/jnnp.2007.121582
5. Claus EB, Park PJ, Carroll R, Chan J, Black PM. Specific genes expressed in association with progesterone receptors in meningioma. Cancer Res (2008) 68(1):314-22. doi:10.1158/0008-5472
6. Kauffman SA. The Origins of Order: Self-Organization and Selection in Evolution. New York, NY: Oxford University Press (1993).
7. Dinicola S, Fabrizio D, Alessia P, Sara P, Elisabetta L, Alessandra C, et al. A systems biology approach to cancer: fractals, attractors, and nonlinear dynamics. OMICS (2011) 15(3):93-104. doi:10.1089/omi.2010.0091
8. Barabási AL, Albert R. Emergence of scaling in random networks. Science (1999) 286:509-12. doi:10.1126/science.286.5439.509
9. Barabási AL, Bonabeau E. Scale-free networks. Sci Am (2003) 288(5):50-9. doi:10.1038/scientificamerican0503-60
10. Barabasi AL. Scale-free networks: a decade and beyond. Science (2009) 325(5939):412-3. doi:10.1126/science.1173299
11. Barabási AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet (2011) 12(1):56-68. doi:10.1038/nrg2918
12. Barabási AL. Network medicine - from obesity to the "diseasome". N Engl J Med (2007) 357(4):404-7. doi:10.1056/full/NEJMe078114
13. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi AL. The human disease network. Proc Natl Acad Sci U S A (2007) 104(21):8685-90. doi:10.1073/pnas.0701361104
14. Liu ZP, Zhan XS, Chen L. Network-based analysis of complex diseases. IET Syst Biol (2012) 6(1):22-33. doi:10.1049/iet-syb.2010.0052
15. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics (2008) 9:559. doi:10.1186/1471-2105-9-559
16. Lee Y, Liu J, Pattel S, Cloughesy T, Lai A, Faroogi H, et al. Genomic landscape of meningiomas. Brain Pathol (2010) 20(4):751-62. doi:10.1111/j.1750-3639.2009.00356.x
17. Langfelder P, Horvath S. Fast R functions for robust correlations and hierarchical clustering. J Stat Softw (2012) 46(11):1-17.
18. Ghazalpour A, Doss S, Zhang B, Wang S, Plaisier C, Castellanos R, et al. Integrating genetic and network analysis to characterize genes related to mouse weight. PLoS Genet (2005) 2(8):e130. doi:10.1371/journal.pgen.0020130
19. Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res (2002) 30(1):207-10. doi:10.1093/nar/30.1.207
20. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets - update. Nucleic Acids Res (2013) 41:D991-5. doi:10.1093/nar/gks1193
21. R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing (2012). Available from: http://www.R-project.org/
22. Gautier L, Cope L, Bolstad BM, Irizarry RA. Affy - analysis of Affymetrix GeneChip data at the probe level. Bioinformatics (2004) 20(3):307-15. doi:10.1093/bioinformatics/btg405
23. Kauffmann A, Gentleman R, Huber W. arrayQualityMetrics - a bioconductor package for quality assessment of microarray data. Bioinformatics (2009) 25(3):415-6. doi:10.1093/bioinformatics/btn647
24. Guy B, Van Helden J. Statistics for Bioinformatics (2013). Available from: http://www.bigre.ulb.ac.be/courses/statistics_bioinformatics/practicals/microarrays_berry_2010/
25. Bengtsson H, Corrada-Bravo H, Gentleman R, Jaffee H. matrixStats: Methods that Apply to Rows and Columns of a Matrix. R package version 0.6.2. (2012).
26. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics (2011) 27(3):431-2. doi:10.1093/bioinformatics/btq675
27. Scardoni G, Petterlini M, Laudanna C. Analyzing biological network parameters with CentiScaPe. Bioinformatics (2009) 25(21):2857-9. doi:10.1093/bioinformatics/btp517
28. Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, et al. ClueGO: a cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics (2009) 25(8):1091-3. doi:10.1093/bioinformatics/btp101
29. The Gene Ontology Consortium. Gene ontology: tool for the unification of biology. Nat Genet (2000) 25(1):25-9. doi:10.1038/75556
30. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular datasets. Nucleic Acids Res (2012) 40:D109-14. doi:10.1093/nar/gkr988
31. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 28:27-30. doi:10.1093/nar/28.1.27
32. Matthews L, Gopinath G, Gillespie M, Caudy M, Croft D, De Bono B, et al. Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res (2009) 37:D619-22. doi:10.1093/nar/gkn863
33. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 4(1):44-57. doi:10.1038/nprot.2008.211
34. Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res (2009) 37(1):1-13. doi:10.1093/nar/gkn923
35. Clayton D. snpStats: SnpMatrix and XSnpMatrix Classes and Methods. R package version 1.6.0. (2012).
36. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res (2012) 40:D930-4. doi:10.1093/nar/gkr917
37. Ho Sui SJ, Fulton DL, Arenillas DJ, Kwon AT, Wasserman WW. oPOSSUM: integrated tools for analysis of regulatory motif over-representation. Nucleic Acids Res (2007) 35(2):W245-52. doi:10.1093/nar/gkm427
38. Subramanian A. From the cover: gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 102(43):15545-50. doi:10.1073/pnas.0506580102
39. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res (2013) 41:D808-15. doi:10.1093/nar/gks1094
40. Tabernero MD, Maillo A, Gil-Bellosta CJ, Castrillo A, Sousa P, Merino M, et al. Gene expression profiles of meningiomas are associated with tumor cytogenetics and patient outcome. Brain Pathol (2009) 19(3):409-20. doi:10.1002/ijc.24568
41. Stuart JE, Lusis EA, Scheck AC, Coons SW, Lal A, Perry A, et al. Identification of gene markers associated with aggressive meningioma by filtering across multiple sets of gene expression arrays. J Neuropathol Exp Neurol (2011) 70(1):1-12. doi:10.1097/NEN.0b013e3182018f1c
42. Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. sva: Surrogate Variable Analysis. R package version 3.2.1.
43. Smyth GK. Limma: linear models for microarray data. In: Gentleman VC, Dudoit S, Irizarry R, Huber W, editors. Bioinformatics and Computational Biology Solutions using R and Bioconductor. New York, NY: Springer (2005). p. 397-420.
44. Tabernero MD, Maíllo A, Nieto AB, Diez-Tascón C, Lara M, Sousa P, et al. Delineation of commonly deleted chromosomal regions in meningiomas by high-density single nucleotide polymorphism genotyping arrays. Genes Chromosomes Cancer (2012) 51(6):606-17. doi:10.1002/gcc.21948
45. GenABEL Project Developers. GenABEL: Genome-Wide SNP Association Analysis. R package version 1.7-4. (2013).
46. Minato Nakazawa. fmsb: Functions for Medical Statistics Book with Some Demographic Data. R package version 0.3.8. (2013).
47. Hastie T, Tibshirani R, Narasimhan B, Chu G. impute: Imputation for Microarray Data. R package version 1.30.0.
48. Mar JC, Matigian NA, Mackay-Sim A, Mellick GD, Sue CM, Silburn PA, et al. Variance of gene expression identifies altered network constraints in neurological disease. PLoS Genet (2011) 7(8):e1002207. doi:10.1371/journal.pgen.1002207
49. Nassehi D, Sørensen LP, Dyrbye H, Thomsen C, Juhler M, Laursen H, et al. Peritumoral brain edema in angiomatous supratentorial meningiomas: an investigation of the vascular endothelial growth factor A pathway. APMIS (2013) 121(11):1025-36. doi:10.1111/apm.12052
50. Collins IM, Beddy P, O'Byrne KJ. Radiological response in an incidental meningioma in a patient treated with chemotherapy combined with CP-751,871, an IGF-1R inhibitor. Acta Oncol (2010) 49(6):872-4. doi:10.3109/02841861003752408
51. Devlin B, Roeder K. Genomic control for association studies. Biometrics (1999) 55(4):997-1004. doi:10.1111/j.0006-341X.1999.00997.x
52. Wejde J, Carlberg M, Hjertman M, Larsson O. Isoprenoid regulation of cell growth: identification of mevalonate-labelled compounds inducing DNA synthesis in human breast cancer cells depleted of serum and mevalonate. J Cell Physiol (1993) 155(3):539-48. doi:10.1002/jcp.1041550312
53. Sundin T, Peffley DM, Gauthier D, Hentosh P. The isoprenoid perillyl alcohol inhibits telomerase activity in prostate cancer cells. Biochimie (2012) 94:2639-48. doi:10.1016/j.biochi.2012.07.028
54. Yoshikawa N, Tsuno NH, Okaji Y, Kawai K, Shuno Y, Nagawa H, et al. Isoprenoid geranylgeranylacetone inhibits human colon cancer cells through induction of apoptosis and cell cycle arrest. Anticancer Drugs (2010) 21(9):850-60. doi:10.1097/CAD.0b013e32833e53cf
55. Rudling MJ, Angelin B, Peterson CO, Collins VP. Low density lipoprotein receptor activity in human intracranial tumors and its relation to the cholesterol requirement. Cancer Res (1990) 50(3):483-7.
56. Osmak M. Statins and cancer: current and future prospects. Cancer Lett (2012) 324:1-12. doi:10.1016/j.canlet.2012.04.011
57. Bergh J, Nilsson K, Dahl D, Andersson L, Virtanen I, Lehto VP. Expression of intermediate filaments in established human lung cancer cell lines. An indicator of differentiation and derivation. Lab Invest (1984) 3(51):307-12.
58. Bell CD, Tischler EM, Laroye GJ. The relationship of cytoplasmic intermediate filaments and membrane antigens with hormone receptors, nuclear staining density, and mode of stromal invasion in human breast cancer. Breast Cancer Res Treat (1995) 33(2):147-62. doi:10.1007/BF00682722
59. Garusi E, Rossi S, Perris R. Antithetic roles of proteoglycans in cancer. Cell Mol Life Sci (2012) 69(4):553-79. doi:10.1007/s00018-011-0816-1
60. Iozzo RV, Sanderson RD. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med (2011) 15(5):1013-31. doi:10.1111/j.1582-4934.2010.01236.x
61. Yang FY, Guan QK, Cui YH, Zhao ZQ, Rao W, Xi Z. NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer: a meta-analysis based on 21 case-control studies. Eur J Cancer Prev (2012) 21(5):432-41. doi:10.1097/CEJ.0b013e32834f7514
62. Yoon CH, Kim MJ, Lee H, Kim RK, Lim EJ, Yoo KC, et al. PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population. J Biol Chem (2012) 23(287):19516-27. doi:10.1074/jbc.M111.337428
63. Shimo A, Nishidate T, Ohta T, Fukuda M, Nakamura Y, Katagiri T. Elevated expression of protein regulator of cytokinesis 1, involved in the growth of breast cancer cells. Cancer Sci (2007) 98(2):174-81. doi:10.1111/j.1349-7006.2006.00381.x
64. Shrestha S, Wilmeth LJ, Eyer J, Shuster CB. PRC1 controls spindle polarization and recruitment of cytokinetic factors during monopolar cytokinesis. Mol Biol Cell (2012) 7(23):1196-207. doi:10.1091/mbc.E11-12-1008
65. Kim HE, Kim DG, Lee KJ, Son JG, Song MY, Park YM, et al. Frequent amplification of CENPF, GMNN and CDK13 genes in hepatocellular carcinomas. PLoS One (2012) 7(8):e43223. doi:10.1371/journal.pone.0043223
66. Horvath S, Zhang B, Carlson M, Lu KV, Zhu S, Felciano RM, et al. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A (2006) 103(46):17402-7. doi:10.1073/pnas.0608396103
67. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, et al. Functional organization of the transcriptome in human brain. Nat Neurosci (2008) 11(11):1271-82. doi:10.1038/nn.2207
68. Mason MJ, Fan G, Plath K, Zhou Q, Horvath S. Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cells. BMC Genomics (2009) 10(1):327. doi:10.1186/1471-2164-10-327
69. Lara-Gonzalez P, Westhorpe FG, Taylor SS. The spindle assembly checkpoint. Curr Biol (2012) 22(22):R966-80. doi:10.1016/j.cub.2012.10.006
70. Schuyler SC, Wu YF, Kuan VJ. The Mad1-Mad2 balancing act - a damaged spindle checkpoint in chromosome instability and cancer. J Cell Sci (2012) 125(18):4197-206. doi:10.1242/jcs.107037
71. Lee KY, Davies T, Mishima M. Cytokinesis microtubule organisers at a glance. J Cell Sci (2012) 125(15):3495-500. doi:10.1242/jcs.094672
72. Wang JF, She L, Su BH, Ding LC, Zheng FF, Zheng DL, et al. CDH12 promotes the invasion of salivary adenoid cystic carcinoma. Oncol Rep (2011) 1:101-8. doi:10.3892/or.2011.1286
73. Lin YL, He ZK, Li ZG, Guan TY. Downregulation of CDH13 expression promotes invasiveness of bladder transitional cell carcinoma. Urol Int (2013) 90(2):225-32. doi:10.1159/000345054
74. Wang Z, Yuan X, Jiao N, Zhu H, Zhang Y, Tong J. CDH13 and FLBN3 gene methylation are associated with poor prognosis in colorectal cancer. Pathol Oncol Res (2012) 18(2):263-70. doi:10.1007/s12253-011-9437-0
75. Plein A, Fantin A, Ruhrberg C. Neuropilin regulation of angiogenesis, arteriogenesis, and vascultar permeability. Microcirculation (2014) 21(4):315-23. doi:10.1111/micc.12124
76. Patnaik A, Lorusso PM, Messersmith WA, Papadopoulos KP, Gore L, Beeram M, et al. A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol (2014) 73(5):951-60. doi:10.1007/s00280-014-2426-8
77. Lou E, Sumrall AL, Turner S, Peters KB, Desjardins A, Vredenburgh JJ, et al. Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series. J Neurooncol (2012) 109(1):63-70. doi:10.1007/s11060-012-0861-0
78. Jensen RL, Petr M, Wurster RD. Calcium channel antagonist effect on in vitro meningioma signal transduction pathways after growth factor stimulation. Neurosurgery (2000) 46(3):692-702. doi:10.1097/00006123-200003000-00032
79. Ragel BT, Couldwell WT, Wurster RD, Jensen RL. Chronic suppressive therapy with calcium channel antagonists for refractory meningiomas. Neurosurg Focus (2007) 23(4):E10. doi:10.3171/FOC-07/10/E10
80. Willard SS, Koochekpour S. Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications. Int J Biol Sci (2013) 9(7):728-42. doi:10.7150/ijbs.6475
81. Cattaneo M, Lotti LV, Martino S, Alessio M, Conti A, Bachi A, et al. Secretion of novel SEL1L endogenous variants is promoted by ER stress/UPR via endosomes and shed vesicles in human cancer cells. PLoS One (2011) 6(2):e17206. doi:10.1371/journal.pone.0017206
82. Ashktorab H, Green W, Finzi G, Sessa F, Nouraie M, Lee EL, et al. SEL1L, an UPR response protein, a potential marker of colonic cell transformation. Dig Dis Sci (2012) 57(4):905-12. doi:10.1007/s10620-011-2026-y
83. Horimoto S, Ninagawa S, Okada T, Koba H, Sugimoto T, Kamiya Y, et al. The unfolded protein response transducer ATF6 represents a novel transmembrane-type endoplasmic reticulum-associated degradation substrate requiring both mannose trimming and SEL1L protein. J Biol Chem (2013) 288(44):31517-27. doi:10.1074/jbc.M113.476010
84. Katoh M, Igarashi M, Fukuda H, Nakagama H, Katoh M. Cancer genetics and genomics of human FOX family genes. Cancer Lett (2013) 328(2):198-206. doi:10.1016/j.canlet.2012.09.017
85. Haria D, Naora H. Homeobox gene deregulation: impact on the hallmarks of cancer. Cancer Hallm (2013) 1(2-3):67-76. doi:10.1166/ch.2013.1007
86. Ben Gacem R, Ben Abdelkrim O, Ziadi S, Ben Dhiab M, Trimeche M. Methylation of miR-124a-1, miR-124a-2, and miR-124a-3 genes correlates with aggressive and advanced breast cancer disease. Tumour Biol (2013) 35(5):4047-56. doi:10.1007/s13277-013-1530-4
87. Xie YL, Yang YJ, Tang C, Sheng HJ, Jiang Y, Han K, et al. Estrogen combined with progesterone decreases cell proliferation and inhibits the expression of Bcl-2 via microRNA let-7a and miR-34b in ovarian cancer cells. Clin Transl Oncol (2014). doi:10.1007/s12094-014-1166-x
88. Zhang S, Qian J, Cao Q, Li P, Wang M, Wang J, et al. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with renal cell cancer risk in a Chinese population. Mutagenesis (2014) 29(2):149-54. doi:10.1093/mutage/geu001
89. Xie K, Liu J, Chen J, Dong J, Ma H, Liu Y, et al. Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer. Gene (2014) 543(1):101-7. doi:10.1016/j.gene.2014.03.059